Showing results (61-70 of 1,054) with videos related to
Sort By:
Pageof 106
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptorsA Fatatis, L A Holtzclaw, R Avidor, et al.Brain Research|April 28, 2000
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's diseaseD Offen, Y Sherki, E Melamed, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1982
Electrical development in spinal cord cell cultureM B Jackson, H Lecar, D E Brenneman, et al.Journal of Child Neurology|January 1, 1994
Regional differences in the critical period neurodevelopment in the mouse: implications for neonatal seizuresM J Litzinger, C L Mouritsen, B B Grover, et al.Regulatory Peptides|October 27, 1999
Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanismsH Y Wang, X Jiang, I Gozes, et al.Annals of the New York Academy of Sciences|February 3, 1999
VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptideD E Brenneman, G Glazner, J M Hill, et al.Annals of the New York Academy of Sciences|February 17, 2000
Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophismD E Brenneman, J Hauser, T M Phillips, et al.International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|June 1, 1995
Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survivalD E Brenneman, J M Hill, G W Glazner, et al.Brain Research|February 19, 1993
HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonatesJ M Hill, R F Mervis, R Avidor, et al.The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndromeC Y Spong, D T Abebe, I Gozes, et al.Pageof 106